Figure 1.
Number of submissions and publications in the past 3 years.
In this paper, we introduce a new form of hybrid censoring sample, that is called COMBINED-UNIFIED (C-U) hybrid sample. In this unified approach, we merge the combined hybrid censoring sampling that considered by Huang and Yang [
Citation: Walid Emam, Khalaf S. Sultan. Bayesian and maximum likelihood estimations of the Dagum parameters under combined-unified hybrid censoring[J]. Mathematical Biosciences and Engineering, 2021, 18(3): 2930-2951. doi: 10.3934/mbe.2021148
| [1] | Marcella Reale . Annual Report 2020. AIMS Allergy and Immunology, 2021, 5(1): 33-37. doi: 10.3934/Allergy.2021003 |
| [2] | Marcella Reale . Annual Report 2021. AIMS Allergy and Immunology, 2022, 6(1): 1-5. doi: 10.3934/Allergy.2022001 |
| [3] | Marcella Reale, Xu Guo . Annual Report 2024. AIMS Allergy and Immunology, 2025, 9(1): 1-7. doi: 10.3934/Allergy.2025001 |
| [4] | Marcella Reale . Annual Report 2022. AIMS Allergy and Immunology, 2023, 7(1): 40-44. doi: 10.3934/Allergy.2023003 |
| [5] | Hui-Min Zhang, Qi-Ling Yin, You-Qiong Liu, Ya-Le Zhang, Wei-Hua Zhang . Recurrent Kawasaki disease in children: Four case reports. AIMS Allergy and Immunology, 2025, 9(2): 123-135. doi: 10.3934/Allergy.2025009 |
| [6] | Bono Eleonora, Zucca Federica, Ortolani Valeria Giuseppina Rita, Caron Lea, Eplite Angelo, Carsana Luca, Iemoli Enrico . Non-allergic rhinitis with eosinophilia syndrome treated with mepolizumab: A case report. AIMS Allergy and Immunology, 2023, 7(3): 176-182. doi: 10.3934/Allergy.2023012 |
| [7] | Swathi Mukurala, Jahanavi Bandla, Swetha kappala . Angioedema-post COVID symptoms. AIMS Allergy and Immunology, 2023, 7(4): 273-280. doi: 10.3934/Allergy.2023018 |
| [8] | Howard Mason, Kate Jones . Airborne exposure to laboratory animal allergens: 2005–2022. AIMS Allergy and Immunology, 2024, 8(1): 18-33. doi: 10.3934/Allergy.2024003 |
| [9] | Richard A. Maiella, Kelly M. Staples, Ashokvardhan Veldanda . Migratory dermatographic urticaria following COVID-19 vaccine booster in young adult male. AIMS Allergy and Immunology, 2022, 6(1): 14-18. doi: 10.3934/Allergy.2022003 |
| [10] | Joe Khodeir, Paul Ohanian, Ali Awwad . Mycobacterium chelonae-induced granulomatous nodules following botulinum toxin injections: A case report and literature review. AIMS Allergy and Immunology, 2024, 8(4): 296-302. doi: 10.3934/Allergy.2024018 |
In this paper, we introduce a new form of hybrid censoring sample, that is called COMBINED-UNIFIED (C-U) hybrid sample. In this unified approach, we merge the combined hybrid censoring sampling that considered by Huang and Yang [
AIMS Allergy and Immunology is an international Open Access journal devoted to publishing peer-reviewed, high quality, original papers in the field of immunology and allergy. At the beginning of the new year and together with the Editorial Office of AIMS Allergy and Immunology, I wish to testify my sincere gratitude to all authors, members of the editorial board and reviewers for their contribution to AIMS Allergy and Immunology in 2023, now we hope we could cooperate with you more this year.
In 2023, We received 26 manuscripts and 20 were published; these published papers include 8 Review articles, 6 Research articles, 2 Mini review, 1 Letter, 1 Case report, 1 Commentary and 1 Editorial. The authors of the manuscripts are from more than 10 countries. The data shows a significant increase of international collaborations on the research of allergy and immunology. During this 2023 we had 46% rejection ratio and publication time (from submission to online) was 94 days, illustrating the strict and efficient review process.
I'm delighted to share that our journal was got its first impact factor (0.7) in 2023. Congratulations!
I would like to share this exciting news with you and hope it could be a 2024 gift for our editorial board members. This is a further sign of the good work done in recent years. I'd like to express my gratitude to everyone who contributed to the journal. This will not only be a new landmark for our journal but also a great encouragement for all its supporters. This is the result of our efforts throughout the year. In fact, In 2023, the special issue “Young Investigator” published 9 articles.
In recognition of authors' expertise the Best Paper Award was launched by AIMS Allergy and Immunology and the manuscript “The immune system through the ages” (AIMS Allergy and Immunology, 2022, 6(3): 170–187), was the winner.
AIMS Allergy and Immunology editorial board has 71 members now, and 2 of which joined in 2023. We will continue to renew editorial board in 2024.
The road is still long and winding but we hope that in 2024, with the support of all the members of the editorial board and reviewers, AIMS Allergy and Immunology can receive and collect more excellent articles to be able to publish. The journal will dedicate to publishing high quality papers by regular issues as well as special issues organized by the members of the editorial board. We believe that all these efforts will increase the impact and citations of the papers published by AIMS Allergy and Immunology.
Please feel free to let us know your opinions, we will follow your suggestions and make updates to improve AIMS Allergy and Immunology.
Prof. Marcella Reale, Editor-in-Chief
AIMS Allergy and Immunology journal
Dept. of Innovative Technologies in Medicine and Dentistry
University “G. d'Annunzio” Chieti-Pescara
Via dei Vestini, Chieti, Italy
The publications of our AIMS Allergy and Immunology journal in 2023 increased (Figure 1). The journal received a total of 26 submissions, and 20 were online, with a rejection rate of 46%, which shows that, despite the decrease in submission, the quality of submissions has improved. The publication time (from submission to online) was 94 days, illustrating the efficient review process. In 2023, AIMS Allergy and Immunology places greater emphasis on publishing high-quality articles and hopes to receive more citations.
Figures 2 and 3 provide the counts of submitted and online manuscripts per country and region. The country and region are derived by affiliation of the corresponding author. The authors of the manuscripts come from more than 10 countries and regions. Submissions to AIMS Allergy and Immunology are mostly from countries in Asia and Europe, such as China, Italy, etc.; final online papers are mostly from countries such as Italy, USA, etc.
We counted the categories of published articles (Table 1). These published papers include 8 Review articles, 6 Research articles, 2 Mini review, 1 Letter, 1 Case report, 1 Commentary and 1 Editorial.
| Type | Number |
| Review | 8 |
| Research article | 6 |
| Mini review | 2 |
| Letter | 1 |
| Case report | 1 |
| Commentary | 1 |
| Editorial | 1 |
DownLoad:
CSV
In 2023, AIMS Allergy and Immunology received its first Impact Factor (0.7), which is of great significance for the development of our journal. The following are specific metrics of articles in the journal.
Table 2 shows the top ten manuscripts in terms of downloads and views in last two years. This will be a motivation for the future promotion of journals and to help them get into the desired databases as early as possible (Data from journal homepage as of January 15, 2024).
| No. | Title | Viewed |
| 1 | Migratory dermatographic urticaria following COVID-19 vaccine booster in young adult male | 6692 |
| 2 | The gastrointestinal effects amongst Ehlers-Danlos syndrome, mast cell activation syndrome and postural orthostatic tachycardia syndrome | 4036 |
| 3 | Understanding sex differences in the allergic immune response to food | 1830 |
| 4 | Multiple sclerosis and allergic diseases: is there a relationship? | 1706 |
| 5 | Dietary and orally-delivered miRNAs: are they functional and ready to modulate immunity? | 1473 |
| 6 | Urinary VPAC1: A potential biomarker in prostate cancer | 1438 |
| 7 | Mast cells: A dark horse in osteoarthritis treatment | 1232 |
| 8 | Epigenetic regulation of the COVID-19 pathogenesis: its impact on the host immune response and disease progression | 1215 |
| 9 | A systematic review of the knowledge and training of food service workers on food allergies | 1148 |
| 10 | Glucuronoxylomannan: the salient polysaccharide in cryptococcal immunity | 1119 |
DownLoad:
CSV
Table 3 shows the top seven manuscripts in terms of citations in last two years. This will help us increase the visibility and impact of the journal (Data from Web of Science as of January 15, 2024).
| No. | Article | Citations |
| 1 | Assessment of efficacy of secondary prophylactic complex of bronchial obstruction syndrome in young children with respiratory disorders in neonatal period: analysis of symptoms and serological markers | 16 |
| 2 | Spleen in innate and adaptive immunity regulation | 14 |
| 3 | Homeostatic proliferation as a physiological process and a risk factor for autoimmune pathology | 6 |
| 4 | Systematic review on the clinical presentation and management of the COVID-19 associated multisystem inflammatory syndrome in children (MIS-C) | 4 |
| 5 | Role of RP105 and A20 in negative regulation of toll-like receptor activity in fibrosis: potential targets for therapeutic intervention | 4 |
| 6 | Antibody profiling reveals gender differences in response to SARS-COVID-2 infection | 4 |
| 7 | Role of RP105 and A20 in negative regulation of toll-like receptor activity in fibrosis: potential targets for therapeutic intervention | 4 |
DownLoad:
CSV
The “Young Investigator” Special Issue was launched by our editor-in-chief Prof. Marcella Reale with the aims to act a showcase for young scientist by allowing them to publish the results of their researches, foster knowledge of their colleagues' research in the field of allergy and immunology and fostering their interactions and professional development. This Special Issue attracted a great deal of attention and 9 papers published so far (Table 4).
Special issue
Young Investigator
Special issue editor: Prof. Marcella Reale
https://www.aimspress.com/allergy/article/6071/special-articles
| No. | Article |
| 1 | Understanding sex differences in the allergic immune response to food |
| 2 | Multiple sclerosis and allergic diseases: is there a relationship? |
| 3 | Mast cells in severe respiratory virus infections: insights for treatment and vaccine administration |
| 4 | Dietary and orally-delivered miRNAs: are they functional and ready to modulate immunity? |
| 5 | Non-allergic rhinitis with eosinophilia syndrome treated with mepolizumab: A case report |
| 6 | The journey so far with SARS-CoV-2 variants: Pathogenesis, immunity and treatments |
| 7 | Exploring ginseng's potential role as an adjuvant therapy in COVID-19 |
| 8 | Angioedema-post COVID symptoms |
| 9 | Suspected ALPS with clinical and laboratory findings: Three patients—three different diagnoses |
DownLoad:
CSV
AIMS Allergy and Immunology has Editorial Board members representing researchers from 19 countries, which are shown in Figure 4. We are constantly assembling the editorial board to be representative to a variety of disciplines across the field of allergy and immunology. AIMS Allergy and Immunology has 71 members now, and 2 of them joined in 2023 (Dr. Campana from Medical University of Vienna with h-index of 27 and Dr. Alexiou from AFNP Med Company with h-index of 23). We will continue to invite dedicated experts and researchers in order to renew the Editorial Board in 2024.
In 2023, our journal developed smoothly. We have received 26 submissions and published 20 papers. The processing period (from received to published) and acceptance rate all remains stable. Each submitted article is processed carefully, fairly, promptly, and the accepted papers appear in the journal in the shortest time. In the past year, with the actively support of the authors, we have successfully published 9 papers in “Young Investigator” Special Issue. In 2023, with the support of the editorial board members and the editor-in-chief, as well as the contributions of authors and reviewers, AIMS Allergy and Immunology received its first Impact Factor (0.7).
In 2024, we expect to publish more articles to enhance the reputation: (1) We will invite more experts in the field of allergy and immunology to publish a review or research article. (2) We will increase influence by soliciting and advertising high quality articles and special issues (topics). (3) We seek to be indexed by more databases. (4) We will continued enlargement of the Editorial Board. (5) We will assign the Best Paper Award for 2023.
| [1] | W. T. Huang, K. C. Yang, A new hybrid censoring scheme and some of its properties, Tam. Oxf. J. Math. Sci., 26 (2010), 355–367. |
| [2] | N. Balakrishnan, A. Rasouli, N. S. Farsipour, Exact likelihood inference based on an unified hybrid censored sample from the exponential distribution, J. Stat. Comput. Simul., 78 (2013), 475–488. |
| [3] |
B. Epstein, Truncated life tests in the exponential case, Ann. Math. Stat., 25 (1954), 555–564. doi: 10.1214/aoms/1177728723
|
| [4] |
K. Fairbanks, R. Madson, R. Dykstra, A confidence interval for an exponential parameter from a hybrid life test, J. Amer. Stat. Assoc., 77 (1982), 137–140. doi: 10.1080/01621459.1982.10477776
|
| [5] |
N. Draper, I. Guttman, Bayesian analysis of hybrid life tests with exponential failure times, Ann. Inst. Stat. Math., 39 (1987), 219–225. doi: 10.1007/BF02491461
|
| [6] |
S. Chen, G. K. Bhattacharya, Exact confidence bounds for an exponential parameter under hybrid censoring, Comm. Stat. Theor. Meth., 17 (1988), 1857–1870. doi: 10.1080/03610928808829718
|
| [7] |
H. S. Jeong, J. I. Park, B. J. Yum, Development of hybrid sampling plans for exponential lifetime distributions, J. Appl. Stat., 23 (1996), 601–607. doi: 10.1080/02664769623964
|
| [8] | A. Childs, B. Chandrasekhar, N. Balakrishnan, D. Kundu, Exact likelihood inference based on Type-Ⅰ and Type-Ⅱ hybrid censored samples from the exponential distribution, Ann. Inst. Stat. Math., 55 (2003), 319–330. |
| [9] | R. D. Gupta, D. Kundu, On the comparison of Fisher information matrices of the Weibull and generalized exponential distributions. J. Stat. Plann. Infer., 136 (2006), 3130–3144. |
| [10] |
N. Balakrishnan, D. Kundu, Hybrid censoring: Models, inferential results and applications, Comput. Stat. Data Anal., 57 (2013), 166–209. doi: 10.1016/j.csda.2012.03.025
|
| [11] |
L. Wang, Y. M. Tripathi, C. Lodhi, Inference procedures for Weibull competing risks model with partially observed failure causes under generalized progressive hybrid censoring, J. Compu. Appl. Math., 368 (2020), 112537. doi: 10.1016/j.cam.2019.112537
|
| [12] |
Y. E. Jeon, S.-B. Kang, Estimation for the half-logistic distribution based on multiply Type-Ⅱ hybrid censoring, Phys. A, 550 (2020), 124501. doi: 10.1016/j.physa.2020.124501
|
| [13] |
M. Nassar, S. A. Dobbah, Analysis of reliability characteristics of bathtub-shaped distribution under adaptive Type-Ⅰ progressive hybrid censoring, IEEE Access, 8 (2020), 181796–181806. doi: 10.1109/ACCESS.2020.3029023
|
| [14] | A. Algarni, A. Almarashi, G. A. Abd-Elmougoud, Joint Type-Ⅰ generalized hybrid censoring for estimation two Weibull distributions, J. Inf. Sci. Eng., 36 (2020), 1243–1260. |
| [15] | C. Dagum, A model of income distribution and the conditions of existence of moments of finite order, Bull. Int. Stat. Inst., 46 (Proceedings of the 40th Session of the ISI, Warsaw, Contributed Papers) (1975), 199–205. |
| [16] | C. Dagum, A new model of personal income distribution: Specification and estimation, Econ. Appl., 30 (1977), 413–437. |
| [17] | C. Dagum, The generation and distribution of income, the Lorenz curve and the Gini ratio, Econom. Appliquf., 33 (1980), 327–367. |
| [18] | C. Dagum, Generating systems and properties of income distribution models, Metron, 38 (1988), 3–26. |
| [19] | C. Kleiber, S. Kotz, Statistical Size Distribution in Economics and Actuarial Sciences, John Wiley & Sons, Hoboken, NJ, 2003. |
| [20] | C. Kleiber, A guide to the Dagum distribution, modeling income distributions and Lorenz curves economic studies in equality, Soc. Excl. Well-Being, 5 (2008), 97–117. |
| [21] |
C. Quintano, A. D'Agostino, Studying inequality in income distribution of singleperson households in four developed countries, Rev. Inc. Weal., 52 (2006), 525–546. doi: 10.1111/j.1475-4991.2006.00206.x
|
| [22] | F. Domma, S. Giordano, M. Zenga, The Fisher information matrix in doubly censored data from the Dagum distribution, Working Paper 8 (2009), Department of Economics and Statistics, University of Calabria, Italy. |
| [23] | F. Domma, C. Latorre, M. Zenga, Reliability studies of the Dagum distribution, Working Paper 207 (2011), Department of Quantitative Methods for Economics and Business, University of Milan - Bicocca, Italy. |
| [24] | F. Domma, L. Andamento, Della hazard function nel modello di Dagum a tre parametri, Quaderni di Statistica, 4 (2002), 103–114. |
| [25] |
D. Kundu, A. Joarder, Analysis of Type-Ⅱ progressively hybrid censored data, Comput. Stat. Data Anal., 50 (2006), 2509–2528. doi: 10.1016/j.csda.2005.05.002
|
| [26] |
M. Dube, R. Garg, H. Krishna, On progressively first failure censored Lindley distribution, Compu. Stat., 31 (2016), 139–163. doi: 10.1007/s00180-015-0622-6
|
| [27] | E. K. AL-Hussaini, G. R. Al-Dayian, S. A. Adham, On finite mixture of two-component Gompertz lifetime model. J. Statist. Comput. Simul., 67 (2000), 1–20. |
| [28] |
L. Tierney, J. B. Kadane, Accurate approximations for posterior moments and marginal densities, J. Amer. Stat. Ass., 81 (1986), 82–86. doi: 10.1080/01621459.1986.10478240
|
| [29] |
M. D. Nicholas, W. J. Padgett, A bootstrap control chart for Weibull percentiles, Qual. Reliab. Eng. Int., 22 (2006), 141–151. doi: 10.1002/qre.691
|
| [30] |
S. Dey, B. Al-Zahrani, S. Basloom, Dagum distribution: Properties and different methods of estimation, Int. J. Stat. Prob., 6 (2017), 74–92. doi: 10.5539/ijsp.v6n2p74
|
Walid Emam, Khalaf S. Sultan. Bayesian and maximum likelihood estimations of the Dagum parameters under combined-unified hybrid censoring[J]. Mathematical Biosciences and Engineering, 2021, 18(3): 2930-2951. doi: 10.3934/mbe.2021148
| Type | Number |
| Review | 8 |
| Research article | 6 |
| Mini review | 2 |
| Letter | 1 |
| Case report | 1 |
| Commentary | 1 |
| Editorial | 1 |
DownLoad:
CSV
| No. | Title | Viewed |
| 1 | Migratory dermatographic urticaria following COVID-19 vaccine booster in young adult male | 6692 |
| 2 | The gastrointestinal effects amongst Ehlers-Danlos syndrome, mast cell activation syndrome and postural orthostatic tachycardia syndrome | 4036 |
| 3 | Understanding sex differences in the allergic immune response to food | 1830 |
| 4 | Multiple sclerosis and allergic diseases: is there a relationship? | 1706 |
| 5 | Dietary and orally-delivered miRNAs: are they functional and ready to modulate immunity? | 1473 |
| 6 | Urinary VPAC1: A potential biomarker in prostate cancer | 1438 |
| 7 | Mast cells: A dark horse in osteoarthritis treatment | 1232 |
| 8 | Epigenetic regulation of the COVID-19 pathogenesis: its impact on the host immune response and disease progression | 1215 |
| 9 | A systematic review of the knowledge and training of food service workers on food allergies | 1148 |
| 10 | Glucuronoxylomannan: the salient polysaccharide in cryptococcal immunity | 1119 |
DownLoad:
CSV
| No. | Article | Citations |
| 1 | Assessment of efficacy of secondary prophylactic complex of bronchial obstruction syndrome in young children with respiratory disorders in neonatal period: analysis of symptoms and serological markers | 16 |
| 2 | Spleen in innate and adaptive immunity regulation | 14 |
| 3 | Homeostatic proliferation as a physiological process and a risk factor for autoimmune pathology | 6 |
| 4 | Systematic review on the clinical presentation and management of the COVID-19 associated multisystem inflammatory syndrome in children (MIS-C) | 4 |
| 5 | Role of RP105 and A20 in negative regulation of toll-like receptor activity in fibrosis: potential targets for therapeutic intervention | 4 |
| 6 | Antibody profiling reveals gender differences in response to SARS-COVID-2 infection | 4 |
| 7 | Role of RP105 and A20 in negative regulation of toll-like receptor activity in fibrosis: potential targets for therapeutic intervention | 4 |
DownLoad:
CSV
| No. | Article |
| 1 | Understanding sex differences in the allergic immune response to food |
| 2 | Multiple sclerosis and allergic diseases: is there a relationship? |
| 3 | Mast cells in severe respiratory virus infections: insights for treatment and vaccine administration |
| 4 | Dietary and orally-delivered miRNAs: are they functional and ready to modulate immunity? |
| 5 | Non-allergic rhinitis with eosinophilia syndrome treated with mepolizumab: A case report |
| 6 | The journey so far with SARS-CoV-2 variants: Pathogenesis, immunity and treatments |
| 7 | Exploring ginseng's potential role as an adjuvant therapy in COVID-19 |
| 8 | Angioedema-post COVID symptoms |
| 9 | Suspected ALPS with clinical and laboratory findings: Three patients—three different diagnoses |
DownLoad:
CSV
| Type | Number |
| Review | 8 |
| Research article | 6 |
| Mini review | 2 |
| Letter | 1 |
| Case report | 1 |
| Commentary | 1 |
| Editorial | 1 |
| No. | Title | Viewed |
| 1 | Migratory dermatographic urticaria following COVID-19 vaccine booster in young adult male | 6692 |
| 2 | The gastrointestinal effects amongst Ehlers-Danlos syndrome, mast cell activation syndrome and postural orthostatic tachycardia syndrome | 4036 |
| 3 | Understanding sex differences in the allergic immune response to food | 1830 |
| 4 | Multiple sclerosis and allergic diseases: is there a relationship? | 1706 |
| 5 | Dietary and orally-delivered miRNAs: are they functional and ready to modulate immunity? | 1473 |
| 6 | Urinary VPAC1: A potential biomarker in prostate cancer | 1438 |
| 7 | Mast cells: A dark horse in osteoarthritis treatment | 1232 |
| 8 | Epigenetic regulation of the COVID-19 pathogenesis: its impact on the host immune response and disease progression | 1215 |
| 9 | A systematic review of the knowledge and training of food service workers on food allergies | 1148 |
| 10 | Glucuronoxylomannan: the salient polysaccharide in cryptococcal immunity | 1119 |
| No. | Article | Citations |
| 1 | Assessment of efficacy of secondary prophylactic complex of bronchial obstruction syndrome in young children with respiratory disorders in neonatal period: analysis of symptoms and serological markers | 16 |
| 2 | Spleen in innate and adaptive immunity regulation | 14 |
| 3 | Homeostatic proliferation as a physiological process and a risk factor for autoimmune pathology | 6 |
| 4 | Systematic review on the clinical presentation and management of the COVID-19 associated multisystem inflammatory syndrome in children (MIS-C) | 4 |
| 5 | Role of RP105 and A20 in negative regulation of toll-like receptor activity in fibrosis: potential targets for therapeutic intervention | 4 |
| 6 | Antibody profiling reveals gender differences in response to SARS-COVID-2 infection | 4 |
| 7 | Role of RP105 and A20 in negative regulation of toll-like receptor activity in fibrosis: potential targets for therapeutic intervention | 4 |
| No. | Article |
| 1 | Understanding sex differences in the allergic immune response to food |
| 2 | Multiple sclerosis and allergic diseases: is there a relationship? |
| 3 | Mast cells in severe respiratory virus infections: insights for treatment and vaccine administration |
| 4 | Dietary and orally-delivered miRNAs: are they functional and ready to modulate immunity? |
| 5 | Non-allergic rhinitis with eosinophilia syndrome treated with mepolizumab: A case report |
| 6 | The journey so far with SARS-CoV-2 variants: Pathogenesis, immunity and treatments |
| 7 | Exploring ginseng's potential role as an adjuvant therapy in COVID-19 |
| 8 | Angioedema-post COVID symptoms |
| 9 | Suspected ALPS with clinical and laboratory findings: Three patients—three different diagnoses |
